tiprankstipranks
Kalaris Therapeutics (KLRS)
NASDAQ:KLRS
US Market
KLRS
Kalaris Therapeutics
RESEARCH TOOLSreports

Kalaris Therapeutics (KLRS) Financial Statements

Compare
375 Followers

Kalaris Therapeutics Financial Overview

Kalaris Therapeutics's market cap is currently $112.99M. The company's EPS TTM is $-0.535; its P/E ratio is -2.97; Kalaris Therapeutics is scheduled to report earnings on March 17, 2026, and the estimated EPS forecast is $-0.53. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ -13.00K$ 0.00$ 0.00$ 0.00$ -1.12M
Operating Income$ -46.15M$ -55.26M$ -13.46M$ -14.01M$ -169.82M
EBITDA$ -46.14M$ -58.77M$ -14.01M$ -15.25M$ -169.84M
Net Income$ -43.44M$ -58.77M$ -14.70M$ -15.48M$ -171.96M
Balance Sheet
Cash & Short-Term Investments$ 117.98M$ 118.29M$ 3.17M$ 3.06M$ 248.12M
Total Assets$ 121.74M$ 118.55M$ 3.33M$ 3.90M$ 286.59M
Total Debt$ 1.45M$ 0.00$ 0.00$ 3.25M$ 30.07M
Net Debt$ -96.61M$ -118.29M$ -3.17M$ 194.00K$ -171.59M
Total Liabilities$ 42.92M$ 5.24M$ 48.35M$ 34.17M$ 61.33M
Stockholders' Equity$ 78.81M$ 113.31M$ -45.02M$ -30.27M$ 225.27M
Cash Flow
Free Cash Flow$ -43.18M$ -67.70M$ -14.13M$ -9.78M$ -106.34M
Operating Cash Flow$ -42.98M$ -67.70M$ -14.13M$ -9.78M$ -106.32M
Investing Cash Flow$ -19.72M$ 95.00M$ 0.00$ 0.00$ 185.98M
Financing Cash Flow$ 159.61M$ 21.00K$ 14.24M$ 12.78M$ 232.00K
Currency in USD

Kalaris Therapeutics Earnings and Revenue History

Income Statement >

Kalaris Therapeutics Debt to Assets

Balance Sheet >

Kalaris Therapeutics Cash Flow

Cash Flow >

Kalaris Therapeutics Forecast EPS vs Actual EPS

Earnings >